Medicine and Dentistry
Cardiovascular Disease
100%
Congestive Heart Failure
54%
Cardiovascular System
37%
Coronary Artery Disease
33%
Human Immunodeficiency Virus
30%
Cardiac Computed Tomography
30%
Acute Coronary Syndrome
27%
Echocardiography
27%
Diseases
27%
Coronary Computed Tomography Angiography
26%
Atrial Fibrillation
22%
Diabetes
21%
Emergency Department
21%
Cardiac Magnetic Resonance Imaging
20%
Atherosclerosis
20%
Polyethylene Terephthalate
19%
Computed Tomography Angiography
17%
Biological Marker
16%
Human Immunodeficiency Virus Infection
16%
Cardiovascular Risk
16%
Gut Microbiome
16%
Coronary Artery Calcium
15%
Coronary Artery Bypass Graft Surgery
15%
Thorax Pain
15%
Prevalence
15%
Sex Hormone Binding Globulin
15%
Systematic Review
15%
COVID-19
14%
Emergency Medicine
14%
Cardiac Sarcoidosis
14%
Diagnosis
14%
Hazard Ratio
14%
Positron Emission Tomography
14%
Risk Stratification
14%
Heart Surgery
14%
Cardiology
13%
Infection
13%
Coronary Angiography
13%
Computer Assisted Tomography
12%
Fluorodeoxyglucose F 18
12%
Cardiac Imaging
12%
Positron Emission Tomography-Computed Tomography
11%
Rubidium 82
11%
UK Biobank
11%
middle age
11%
Malignant Neoplasm
10%
Streptococcus Pneumonia
10%
Cohort Analysis
10%
ST Segment Elevation Myocardial Infarction
10%
Myocardial Perfusion Imaging
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
55%
Congestive Heart Failure
39%
Atherosclerosis
29%
Diseases
29%
Coronary Artery Disease
25%
Inflammation
23%
Acute Coronary Syndrome
21%
Infection
20%
Polyethylene Terephthalate
19%
All Cause Mortality
18%
Coronary Artery Atherosclerosis
18%
Biological Marker
17%
HIV
17%
Cardiovascular Risk
16%
SARS Coronavirus
14%
Atrial Fibrillation
12%
Rubidium 82
11%
Lipoprotein
11%
Cohort Study
10%
Human Immunodeficiency Virus Infection
10%
Sarcoidosis
10%
Sex Hormone Binding Globulin
9%
Malignant Neoplasm
9%
Sodium Glucose Cotransporter 2 Inhibitor
9%
Gout
9%
Cardiac Sarcoidosis
9%
Microbiome
9%
Clinical Trial
7%
Adverse Outcome
7%
Low Density Lipoprotein Cholesterol
6%
Dyslipidemia
6%
Comorbidity
6%
Troponin
5%
Cause of Death
5%
Diastolic Dysfunction
5%
Tracer
5%
Drug Development
5%
Phospholipid
5%
Systolic Dysfunction
5%
Cardiovascular Mortality
5%
Randomized Controlled Trial
5%
Combination Therapy
5%
Prevalence
5%
Nursing and Health Professions
Congestive Heart Failure
22%
Cardiovascular Disease
20%
Coronary Artery Disease
12%
Hospital Readmission
12%
Confidence Interval
11%
Clinical Outcome
10%
Troponin
10%
Systematic Review
9%
Meta Analysis
9%
Coronary Angiography
9%
ST Segment Elevation Myocardial Infarction
9%
Coronary Artery Bypass Graft
7%
Human Immunodeficiency Virus
7%
Medication Compliance
7%
Feature Extraction
7%
Cohort Analysis
6%
Diseases
6%
Health Care Cost
6%
Coronary Artery Recanalization
6%
Heart Muscle Revascularization
6%
Human Immunodeficiency Virus Infection
5%
Clinical Practice
5%
Infection
5%
Dyslipidemia
5%
Non ST Segment Elevation Myocardial Infarction
5%
Hazard Ratio
5%